Abstract A088: Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors
Keyword(s):
2017 ◽
Vol 79
(5)
◽
pp. 915-922
◽
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5565-5565
◽